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Abstract

Limb amputation is a major cause of disability in our community, for which motorised prosthetic devices offer
a return to function and independence. With the commercialisation and increasing availability of advanced
motorised prosthetic technologies, there is a consumer need and clinical drive for intuitive user control. In
this context, rapid additive fabrication/prototyping capacities and biofabrication protocols embrace a highlypersonalised medicine doctrine that marries specific patient biology and anatomy to high-end prosthetic
design, manufacture and functionality. Commercially-available prosthetic models utilise surface electrodes
that are limited by their disconnect between mind and device. As such, alternative strategies of mindprosthetic interfacing have been explored to purposefully drive the prosthetic limb. This review investigates
mind to machine interfacing strategies, with a focus on the biological challenges of long-term harnessing of
the user's cerebral commands to drive actuation/movement in electronic prostheses. It covers the limitations
of skin, peripheral nerve and brain interfacing electrodes, and in particular the challenges of minimising the
foreign-body response, as well as a new strategy of grafting muscle onto residual peripheral nerves. In
conjunction, this review also investigates the applicability of additive tissue engineering at the nerve-electrode
boundary, which has led to pioneering work in neural regeneration and bioelectrode development for
applications at the neuroprosthetic interface.
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Abstract: Limb amputation is a major cause of disability in our community, for which motorised
prosthetic devices offer a return to function and independence. With the commercialisation and
increasing availability of advanced motorised prosthetic technologies, there is a consumer need
and clinical drive for intuitive user control. In this context, rapid additive fabrication/prototyping
capacities and biofabrication protocols embrace a highly-personalised medicine doctrine that marries
specific patient biology and anatomy to high-end prosthetic design, manufacture and functionality.
Commercially-available prosthetic models utilise surface electrodes that are limited by their disconnect
between mind and device. As such, alternative strategies of mind–prosthetic interfacing have been
explored to purposefully drive the prosthetic limb. This review investigates mind to machine
interfacing strategies, with a focus on the biological challenges of long-term harnessing of the user’s
cerebral commands to drive actuation/movement in electronic prostheses. It covers the limitations of
skin, peripheral nerve and brain interfacing electrodes, and in particular the challenges of minimising
the foreign-body response, as well as a new strategy of grafting muscle onto residual peripheral nerves.
In conjunction, this review also investigates the applicability of additive tissue engineering at the
nerve-electrode boundary, which has led to pioneering work in neural regeneration and bioelectrode
development for applications at the neuroprosthetic interface.
Keywords: neuroprosthetic interfacing; artificial limbs; myoelectric control; 3D printing; tissue
engineering; bioprinting

1. Introduction
From Captain Hook to Luke Skywalker, both cinema and science have evolved in their respective
visionary prescience of replacing a missing limb with a functional prosthetic device. Losing a limb can
be a consequence of an unexpected traumatic event, such as in accidents or in combat [1,2]. At other
times, it is a calculated decision of life over limb in the setting of tumour growth or other debilitating
disease processes [3,4]. Facing amputation is a devastating experience with immediate and profound
impact on the patient’s quality of life, as well as for their family, friends and carers [3]. For the surgeon,
these operations are a poignant reminder of our limitations in medicine despite all the advances of
modern technology. It does, however, serve as powerful inspiration to turn the science-fiction of
dextrous, body-integrated robotic limbs into a reality.

Materials 2019, 12, 1927; doi:10.3390/ma12121927

www.mdpi.com/journal/materials

Materials 2019, 12, 1927

2 of 14

Long-standing ‘peg-leg’ and ‘hand-hook’ prosthetics fulfil simple mechanical requirements
and can adequately restore gross motor functions such as standing and walking. These prostheses
are immediately amenable to modern additive fabrication technologies, which is evident in the
recent establishment of numerous manufacturing ventures to rapidly 3D-print bespoke, cost-effective
functional prosthetics for amputees [4,5]. These activities will in future inevitably traverse a marketplace
that encompasses major as well as a smaller commercial entities to provide prosthetics of varying
complexity to furnish simple mechano-structural functionality in cases of lost limbs.
In a similar light, advanced prosthetic technologies with multiple motorised joints have long
been developed and, in fact, are commercially available. Again, advancements in additive fabrication
technologies will inevitably lead to high-throughput fabrication of limb prostheses on a personalised
basis. Unfortunately, their clinical application has been limited due to the fact that these devices must
presently largely be driven without true intuitive motor intent. Examples include prosthetic limbs that
are activated by surface electrodes on remaining muscle groups, or even manual changes of motion
through buttons and smartphone apps [6]. This results in a disconnect between what the brain wants
the robotic limb to do, and how the device is programmed to respond. Thus the critical obstacle for the
adoption of this technology is the interface between the mind and the prosthetic device.
This literature review thus investigates current neuroprosthetic interfacing technologies, with a
focus on long-term integration with endogenous host biology, harnessing the user’s cerebral commands
and how additive biofabrication technologies may ultimately enable achievements of these functions.
It investigates the limitations of skin, peripheral nerve and brain interfacing electrodes, and in particular
the challenges of minimising the foreign-body response, as well as a new innovative strategy of grafting
muscle onto residual peripheral nerves. It also introduces the concept of integrated bio-prosthetic
engineering at the nerve-electrode boundary, which has led to pioneering work in neural regeneration
and bioelectrode development for applications at the neuroprosthetic interface.
2. The Motorised Prosthetic Limb
Prosthetic devices play an important role in rehabilitation after amputation [7]. At a minimum,
they can serve as cosmetic restoration, which can provide psychological benefit and have simple passive
or opposing functions [8]. More advanced prosthetics offer some functional restoration, enabling
activities of daily living such as grooming and dressing, and minimising injury on the contralateral
side from compensation and overuse [9,10]. For the return of basic function, body-powered prosthetics
utilise movement of a proximal joint to operate a terminal device [11]. With this method, the patient
uses movement in the remaining limb to trigger a physiologically unrelated action in the prosthesis e.g.
shoulder flexion and extension may trigger a prosthetic pincer to open and close. Although simple and
effective, this system of pulleys and cables typically allows only one joint to be operated at a time [11].
More sophisticated function requires simultaneous articulated movements, in particular for the human
hand [12]. As such, motorised prosthetic limbs have been developed to offer greater mobility, dexterity
and motor control than purely structural, non-motorised prosthetics.
Robotic arms with multiple degrees of freedom (DOF) and a variety of terminal grippers have
long been used in the manufacturing industry [13]. Similarly, advanced motorised prosthetic limbs
have also been designed with articulated humanoid hands and accompanying grip sequences [14,15].
These are readily prototyped and produced with existing 3D printing technology, requiring low
levels of regulatory approval to translate [16]. Despite these mechatronic and additive biofabrication
advances, the real challenge for achieving functionality of a human prosthetic limb is its integration
with functional biology. Ideally, the prosthesis should be driven by the user’s motor intent and thus
respond to purposeful cerebral commands. Efforts to achieve biological control of such bionic systems
have led to the development of different neuroprosthetic interfacing strategies. These interfacing
electrodes can be broadly categorised by site: on remaining muscle groups, in the peripheral nervous
system (PNS), and in the central nervous system (CNS) (Figure 1).

endovascular stent [50]. Through standard angiography techniques, this device can be delivered and
positioned within the cerebral vasculature to record signals at a resolution similar to ECoG
recordings. This minimally invasive technique has been trialled in the sheep model, where electrodes
were delivered in the cerebral venous system and implanted for up to 190 days [51]. Its potential in
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systems, seizure prediction in epilepsy and deep brain stimulation therapies remain to3 be
explored.

Figure 1. Different methods of achieving mind-control of motorised prosthetic limbs.
Figure 1. Different methods of achieving mind-control of motorised prosthetic limbs.
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[57]. from the limb can be
transferred to denervated sections of nearby muscle [20]. This method demonstrates the remarkable
capacity of muscle to accept innervation from different nerves and has the added benefit of amplifying
neural signals and mitigating the formation of painful neuromas [21]. Most importantly, the signals
from the transected nerve are preserved in several new myoelectric control sites [21]. Another fortuitous
finding from these surgeries is that the transferred nerve can also provide sensation to the overlying
skin, offering potential sites for sensory feedback from the prosthesis [20]. While TMR is a promising
technique for the preservation of neural signals, it faces the same issues as traditional myoelectric
systems, which include the skin–electrode connection, wearing multiple electrodes, and still a limited
overall number of signalling points for triggering the robotic limb. Furthermore, these strategies are
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restricted by size and suitability of surrounding muscle, demand substantial recovery time and are not
truly representative of the user’s intent [22].
An alternative to surface electrodes for the detection of muscle activity is the Implantable
Myoelectric Sensor (IMES) System [23]. IMES electrodes are small cylinders (16 mm long, 2.5 mm
in diameter) that wirelessly transmit myoelectric activity after insertion in the muscle belly. The
IMES system uses six implanted electrodes to allow for simultaneous control of three DOFs, and can
detect activation of deeper muscles not previously recruited with surface recordings. This system also
promises more comfort for the wearer as it does not depend on a tight electrode-skin interface, and so
the prosthesis can be optimised for comfort. The issues with this system are again the same as with all
current myoelectric prosthetic devices; there are limited muscle groups available after amputation, and
the system is not intuitive if the neural signals from the transected nerve are not harnessed.
2.2. Peripheral Nerve Electrodes
Another strategy to achieve prosthetic control is to record directly from peripheral nerves.
Electrodes can be applied either extraneurally or intraneurally to detect signals that reflect the user’s
motor intention. Extraneural electrodes, such as the cuff electrode or Flat Interface Nerve Electrode
(FINE), wrap around the entire nerve bundle and record changes in electrical potential on the perimeter
of the nerve. As such, its spatial resolution is limited due to its superficial position. Cuff electrodes
have been shown to withstand chronic implantation in human peripheral nerve studies, and have
applications for long-term neural stimulation to treat conditions such as chronic pain or bladder
dysfunction [24–26]. However, its poor selectivity of recordings from individual fascicles makes it less
suitable for interpreting the variety of neural signals required to trigger a robotic limb.
Higher spatial resolution can be achieved through penetrating intraneural electrode systems.
Longitudinal Intrafascicular Electrodes (LIFE), Transverse Intrafascicular Multichannel Electrodes
(TIME) and the Utah Slanted Electrode Array (USEA) are all examples of electrode systems that pierce
the epineurium and record from a number of fascicles within the nerve bundle [27–29]. LIFE and
TIME are essentially single wires with several recording points, which are inserted longitudinally
or transversally to address multiple fascicles. This approach, particularly longitudinal insertion,
minimises surgical damage, and these systems have been successfully implanted for up to three
months in animal studies [30]. There is little data on the recording capabilities of these electrodes, but
stimulation studies show promise for recruiting multiple muscle groups [31]. The USEA is the most
invasive example, consisting of an array of electrodes from short to long inserted into the nerve. These
electrodes have the highest spatial resolution, with the most fascicles within recording distance of an
electrode. Its high recording fidelity was demonstrated in two human subjects, who after implantation
of the USEA into their remaining upper limb nerves were able to move individual fingers on a virtual
robotic hand [32]. Its main issue, however, is the damage caused to the nerve after chronic implantation,
due to its invasiveness and issues with micromotion across the array [33,34].
The last peripheral nerve interfacing strategy is the regenerative electrode. These systems can be
described as sieves or hollow electrode array systems, which are placed between two ends of a severed
nerve [35]. The aim is for the nerve to regenerate through the porous electrode, thus optimising its
resolution. The requirement for the nerve to be severed, followed by a highly variable process of neural
regeneration, makes this technology the most invasive of the peripheral nerve electrodes. However,
early animal experiments have demonstrated some neural regeneration over three to four months after
implantation, and that these electrodes can both record and stimulate [36,37].
2.3. Brain–Computer Interfaces
Brain–computer interfaces (BCI) record signals from the CNS to drive the robotic limb. The invasive
nature of these techniques mean that it is mostly limited to subjects with severe disease, such as
paraplegia or quadriplegia, and that they are perhaps less applicable to amputees who are otherwise
systemically well. Nonetheless, it is an important interfacing strategy to consider in the scope of
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neuroprosthetic technology. In conditions where peripheral nerves are not available due to spinal or
brain injury, or severe neuromuscular degeneration, motor intent can be recorded from the brain itself.
Recording electrodes can be categorised by invasiveness, ranging from surface or scalp recordings
(electroencephalography—EEG), cortical recordings (electrocorticography—ECoG), or within the
parenchyma of the brain itself (local field potentials and single-neuron action potential recordings).
EEG is a non-invasive approach that utilises surface electrodes to detect brain activity through
the scalp. Although it is the safest method of recording brain activity, the centimetre’s distance of the
scalp from the brain and the poor transmission through cerebrospinal fluid, skull and skin greatly
hinders the spatial resolution [38]. EEGs have nonetheless been a useful tool for providing a channel
of communication through the control of computer cursors and spelling programs for patients with
severe paralysis, and were a starting point for the interpretation of cortical activity to drive prosthetic
devices [39–41]. Higher resolution recordings can be obtained with ECoG BCI systems, which require
surgical implantation of an electrode array on the surface of the brain. ECoG systems have been
used for decades to intraoperatively identify epileptogenic areas for surgical removal in patients with
intractable seizures [42,43]. More recently, this technology has been used to record motor cortex activity
to control upper limb prosthetics, even achieving individual finger control [44–46].
The highest resolution is achieved with the most invasive approach, which is to implant penetrating
electrodes into the motor cortex. These electrode arrays are able to record local field potential activity or
even individual neurons within the brain. Although the high spatial resolution reflects more intuitive
and accurate motor function, their significant limitation is in maintaining stable long-term recordings
due to the inflammatory reaction and fibrotic capsule formation around the implant [47]. Despite this,
invasive electrodes have been used to direct motion in some of the most advanced prosthetic limbs,
including the DEKA Arm System (Mobius Bionics). Ninety-six-channel microelectrode arrays were
implanted into the motor cortex hand area of two study participants with longstanding quadriplegia,
both of whom were able to operate the DEKA arm to touch and grasp objects [48]. This breakthrough
experiment offered a glimpse into the possibilities of BCI interfacing in a prosthetic arm that boasts
ten powered DOFs [14]. However, this level of control has not yet been achieved with BCI recordings
alone, and indeed the DEKA arm has been made commercially available as a myoelectric prosthesis
coupled with foot controllers [49].
The main resistance to widely applying BCI systems is the obvious surgical and infection
risk that comes with craniotomies for electrode implantation in the CNS. To counter this, a recent
innovation in neural interfacing technology is the development of an electrode array delivered as
an endovascular stent [50]. Through standard angiography techniques, this device can be delivered
and positioned within the cerebral vasculature to record signals at a resolution similar to ECoG
recordings. This minimally invasive technique has been trialled in the sheep model, where electrodes
were delivered in the cerebral venous system and implanted for up to 190 days [51]. Its potential in BCI
systems, seizure prediction in epilepsy and deep brain stimulation therapies remain to be explored.
3. The Challenges of Tissue-Electronic Interfacing
Whether an electrode is positioned in muscle, nerve or brain, its interaction with the surrounding
environment will contribute significantly to its effectiveness and longevity. Minimising the physiological
foreign-body response (FBR) is key to designing any biomedical implant [52]. Outside of the CNS, FBR
begins with the immediate deposition of host proteins on the surface, such as albumin, fibrinogen,
complement, and fibronectin, to initiate the acute inflammatory cellular reaction [53]. The acute
phase is characterised by the presence of neutrophils and histamine release from mast cells. Together,
these cells and their bioactive agents mediate the initial reaction to an implant, further recruiting
monocytes and macrophages to the site [54]. The deposition of protein provides a means of attachment
for macrophages, which can fuse into foreign-body giant cells (FBGC) for the phagocytosis of larger
particles [55]. Biomedical implant devices are typically well beyond the phagocytic capacity of
cells, and in response, these cells release reactive oxygen intermediates, enzymes and acid into their
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environment [56]. Eventually, the over-activation of inflammatory cells leads to the excessive deposition
of collagen from fibroblasts in a process known as fibrous encapsulation, thus walling off the device
and often causing device failure [57].
Of relevance to BCI systems, the foreign-body response within the CNS can be similarly destructive,
with some site-related differences. Although sometimes labelled an ‘immune privileged’ site, the
CNS in fact has an extensive innate immune response, mediated by microglia, oligodendrocytes and
astrocytes, that is similarly capable of mounting a FBR [58–60]. In addition, the trauma of implantation
disrupts the cerebral vasculature, breaking what is known as the blood–brain barrier (BBB), which
introduces blood-borne immune cells to the CNS [61]. While the timeframe of the FBR response in
the CNS may be longer and the overall inflammation somewhat reduced, the inevitable neuronal cell
death and potential for infection are serious risks that must be considered [62,63].
Design considerations to minimise the FBR include matching the material to the surrounding
mechanical stiffness of the tissue, accommodating for any contractile dynamics, and conforming to the
topography of the tissue to maximise contact area [64]. For long-term neural interfacing, the main
challenge is to design implants that mimic the very soft modulus of neural tissue [65]. Traditional
platinum or gold electrode probes are unsuitable for this environment, as they tend to provoke a chronic
inflammatory response with cell death of target neurons [62,63]. As such, long-term invasive recording
systems are difficult to sustain in this delicate neuronal microenvironment, which is sensitive to
disturbance and quick to respond with cell death and scarring. Minimising invasiveness, as mentioned
with the LIFE and TIME electrode wires, can prolong its lifespan but at the cost of recording resolution.
More general strategies can be adopted, which include coating electrodes with anti-inflammatories,
surface modification with hydrophilic polymers, or using anti-adhesive coatings [66–68]. Despite
these advances, long-term neural interfacing is a bioengineering conundrum constantly challenged by
delicate neural biology.
As an alternative, using skeletal muscle as a surrogate for neural interfacing is an attractive
option, although it does present its own unique challenges. Muscle is a much larger and tougher
structure than nerve, with greater regenerative potential, more metabolic reserve and stiffer mechanical
properties [69–72]. The amplitude of EMG signals is far greater than neural signals and thus
easier to record [73]. Its main physiological limitation is its contractile nature, which can shorten
the tissue by up to 20% of its original length [74]. As such, electrodes that are highly flexible
and elastic are required. Conducting polymers that can withstand high strains over many cycles
have been investigated, including polypyrrole, polyaniline and poly(3,4-ethylenedioxythiophene)
(PEDOT) [75–77]. Alternatively, non-conductive flexible materials such as polydimethyl-siloxane
(PDMS) or styrene-butadiene-styrene (SBS) can be combined with conductive nanoparticles [78,79].
Buckling the conductive material on pre-stretched substrates can prevent cracking of the electrode
when implanted in contractile environments, and placement of electrodes in a more mechanically
neutral plane can also minimise the stress on the material [75]. Of note, interfacing with contractile
muscle has been achieved in clinical practice for decades in the cardiac pacemaker, where its lead
wires are typically implanted into the endocardial wall of the heart and can last the lifetime of the
patient [80]. Given the much lower degree of tissue injury and surgical risk, electrode-interfacing with
muscle is biologically more achievable. However, without harnessing the signals from residual nerves
to the missing limb, this strategy will never lead to intuitive prosthetic motor control.
4. Grafting Skeletal Muscle onto Residual Nerves
A solution that marries the biological advantages of muscle with the preservation of neural signals
is the development of a muscle-based Regenerative Peripheral Nerve Interface (RPNI). The RPNI is
an autologous muscle graft neurotised by the free end of the residual nerve [81]. Rat and macaque
studies have demonstrated that peripheral nerves can be dissected down to its fascicles for attachment
to individual RPNIs which become innervated over three to four months [82,83]. In contrast to TMR,
this technique can be applied to any level of amputation and is less constrained by patient anatomy.
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The intraneural dissection also allows for more specific functionality of the muscle recording, which
is key to intuitive prosthetic control. Most recently, RPNIs with intramuscular recording electrodes
were implanted in macaques for up to twenty months. This proof-of-concept study demonstrated
the ability of muscle grafts to be successfully innervated, tolerate chronic electrode implantation, and
record signals that could be decoded to represent individual finger movement [84].
RPNIs consist of small muscle grafts (~1 cm × 3 cm) that are transposed to residual nerves
without a dedicated blood supply. This has been reported as being adequate for tissue survival, with
normal muscle histology present after four months of implantation [83]. The process of innervation of
these grafts is currently in the order of months in small animal models. The authors also noted that
some RPNIs reintegrated into surrounding muscle, making it difficult to isolate EMG signals after
twenty months of implantation [83]. Aside from these limitations, the RPNI is a creative method of
side-stepping the challenges of neural biology, and early functional animal studies show great promise
for achieving sophisticated neuroprosthetic control.
5. Tissue Engineering in the Neuroprosthetic Interface
The drawback to the RPNI is that it relies on grafted muscle, which requires the harvest of
functional, healthy tissue from a patient who has already suffered a significant loss. Moreover, it does
not specifically promote the process of innervation, which is the critical purpose for using such a
graft. An alternative may be to tissue engineer the necessary autologous nerve or muscle through the
combination of progenitor cells, scaffold material and neurotrophic biochemical cues.
Methods of bridging the biological mismatch of tissue and electrode have been explored with
hydrogel polymers, which have the advantage of being amenable to mechanical and biochemical
modification. Blending hydrogels with conductive polymers, such as polypyrrole or PEDOT, have
been explored as a method of mediating the modulus mismatch and providing desirable electrical
characteristics. While attractive in theory, these hybrid materials are limited in their ability to
support neural regeneration and integration and have shown low functionality in short-term in vivo
studies [85–87]. To improve neuronal survival at the electrode surface, a progression from this idea is to
combine hydrogels with neural progenitors and biofactors to create a ‘living electrode’. This approach
adopts the principles of tissue engineering, with the goal of growing an electrode-integrated layer
of fabricated neural tissue to regenerate with transected nerves. Frontier work in this field has led
to preliminary studies demonstrating the concept of neural networks encapsulated in degradable
hydrogels on electrodes [88]. Their functionality is yet to be explored.
Similarly, early efforts to use tissue-engineered muscle for grafting onto transected nerves have
shown promise for the recording of neural signals. Silicon, acellular extracellular matrix (ECM) and
ECM with PEDOT were tested as suitable scaffolds for myotube grafting onto a transected nerve
in vivo [89]. These artificial muscle grafts were attached to nerves in the same manner as RPNI
constructs, and after an average implantation time of 93 days, myoelectric activity was recorded in
response to neural stimulation. Although the biology of this construct was rudimentary and the
inclusion of PEDOT did not enhance the muscle or innervation, it was able to demonstrate the concept
of growing autologous muscle for grafting onto transected nerves, as opposed to harvesting tissue
from elsewhere in the body.
6. Bioprinting and 3D Printing
The process of tissue engineering opens up opportunities to integrate electrode systems into living
structures as part of the fabrication process, ultimately creating bioelectrode devices personalised
to the individual’s anatomy and biology. While there are a variety of techniques to engineer nerve
and muscle, bioprinting is a particularly promising approach for the fabrication of 3D tissues for
integration into bioelectronic systems. It involves the deposition of living cells in additive layers, using a
computer-controlled system to precisely create a pre-planned 3D structure [90]. Current 3D bioprinting
strategies range from laser bioprinting, piezoelectric bioprinting and extrusion bioprinting [91,92].
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For creating structures that can be surgically grafted, and in particular skeletal muscle, extrusion
bioprinting has the advantage of being the only system to deliver high cell density constructs in a
scalable manner.
Extrusion bioprinting uses a ‘bioink’ of cells encapsulated in a hydrogel, which is deposited as
layered filaments to create custom-shaped constructs. The extrusion system typically uses mechanical
or pneumatic pressure to control the flow of bioink through a nozzle that can print down to a resolution
of 100 µm [90]. It enables rapid fabrication of cell-laden hydrogel filaments, and furthermore allows
for precise patterning and construction of highly porous networks. This overcomes the problem of
diffusion distance and offers more opportunity for the infiltration of vasculature and nerves. Although
there are few examples of functional bioprinted muscle or nerve, early results highlight the engineering
versatility of this technique, although acknowledging the requirement for further refinement of the
scaffold material and cell culture conditions [93]. In combination with the aforementioned electrode
technology, the interwoven fabrication of engineered tissue and interfacing electrodes points to exciting
future developments for neuroprosthetic interfacing.
The process of additive manufacturing also extends to the fabrication of the electrode devices
themselves. 3D printing has facilitated rapid production of bespoke laboratory and medical equipment,
with new opportunities for tissue engineering applications [94–96]. It offers creative solutions for cell
cultures systems that might include microfluidics, perfusion technology, and integration of electrodes
into 3D printed devices [97–99]. Of relevance to bioelectrode development and tissue-electrode
interfacing, recent studies have demonstrated the feasibility of 3D printing graphene-based electrodes,
carbon-fibre microelectrodes and stainless steel electrodes [100–102]. Another approach is to 3D print
the device to house the electrode wires [99]. Recognition of imminent innovations in design and
bioengineering led the authors of this paper to publish on the biocompatibility of commonly used
photopolymer 3D-printing inks, and methods of optimizing these materials for cell culture [103]. Such
advances in electrode and device fabrication techniques easily translate to enhancement of tissue
engineering strategies, with obvious creative scope for the simultaneous fabrication of integrated
electrode and cellular structures as a single bioelectrode device.
7. Conclusions
With the commercialisation and increasing availability of advanced motorised prosthetic
technologies, there is a consumer need and clinical drive for intuitive user control. Current models
that utilise surface electrodes are limited by their disconnect between mind and prosthetic device.
Direct neural interfacing, whether it is in the central or peripheral nervous system, has shown that
intuitive control can indeed be achieved. However, the longevity of such systems is challenged by the
foreign-body response, which leads to fibrous encapsulation of the electrodes, neuronal cell death and
failure of the device. To overcome this problem, skeletal muscle has been explored as an alternative
recording source. Neurotised muscle grafts have been demonstrated to amplify neural signals and
have shown potential for side-stepping the challenges of long-term neural interfacing. Lastly, the
scope for direct applications of additive biofabrication technologies, such as 3D rapid-prototyping
and bioprinting, in the manufacture of prosthetic limbs are ever more obvious. Advances in tissue
engineering have led to neural and muscle engineering specifically at the neuroprosthetic interface,
which open up creative possibilities for the integration of innervated tissue with electrodes and the
opportunity to tailor these interfacing systems to the user’s own biology and anatomy. In combination
with advances in biomaterial development and signal processing algorithms, this will likely lead the
way to long-term intuitive motor control of prosthetic limbs.
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